Trial Condition(s):

Wound Healing, Cell proliferation, Gene expression

Study to assess on a molecular level the influence of a 5 % dexpanthenol ointment in subjects with superficial injuries

Bayer Identifier:

13069

ClinicalTrials.gov Identifier:

NCT00859196

EudraCT Number:

2008-002069-30

Study Completed

Trial Purpose

In previous in vitro studies it could be shown, that Dexpanthenol has an influence on the gene expression of fibroblasts. The genes which are influenced by Dexpanthenol play mainly a role during cell proliferating processes.The aim of this study is to investigate the molecular effect of Dexpanthenol on human living skin, during wound healing.

Inclusion Criteria
- Skin type I to IV
 - Willingness to avoid intensive sunlight exposure two weeks before the start of the study and at least 2 months after removal of the stitches
Exclusion Criteria
- Active skin disease, moles, tattoos, strong pigmentation at the test area or scars in the test area that would influence the visual scoring
 - History of keloids and hypertrophic scars
 - Frequent visits of tanning booths
 - Intake of drugs interfering with the immune system (e.g. antiphlogistics, corticosteroids, immunosuppressants, and antihistamines) within 30 days before day 1 as well as during the study.

Trial Summary

Enrollment Goal
15
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
Yes
Products
Dexpanthenol (BAY81-2996)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

proDerm

Hamburg, Germany, 22869

Status
Completed
 

Trial Design